Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
In order to compare the clinical and microbiological efficacies and safety of piperacillin plus tazobactam with those of imipenem plus cilastatin, 134 patients with intra-abdominal infections (73 patients with appendicitis) participated in an open randomized comparative multicenter trial. A total of...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1992
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245542/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1336347/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.12.2766 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
